other
confidence high
sentiment neutral
materiality 0.60
Co-Diagnostics shareholders approve reverse stock split up to 1-for-30
Co-Diagnostics, Inc.
- Special meeting on Dec 5, 2025 approved amendment for reverse stock split.
- Vote: 26,465,960 for, 4,213,378 against, 194,746 abstain – passed.
- Board authorized to set final ratio between 1-for-2 and 1-for-30 within 12 months.
- No other proposals were voted on at the special meeting.